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Introduction: The majority of young women use oral contraceptives (OCs). Use of OCs
has been associated with lower myofibrillar protein and tendon collagen synthesis rates,
but it is unknown whether OCs will limit the adaptive response of myotendinous tissue
to resistance training.
Design and Methods: Fourteen healthy untrained young regular OC users
(24 ± 1 years, fat% 32 ± 1, 35 ± 2 ml·min−1·kg−1) and 14 NOC users (non-
OC, controls) (24 ± 1 years, fat% 32 ± 2, 34 ± 2 ml·min−1·kg−1) performed a
10-week supervised lower extremity progressive resistance training program. Before
and after the intervention biopsies from the vastus lateralis muscle and the patellar
tendon were obtained. Muscle (quadriceps) and tendon cross-sectional area (CSA)
was determined by magnetic resonance imaging (MRI) scans, and muscle fiber
CSA was determined by histochemistry. Maximal isometric knee extension strength
was assessed by dynamometry while 1 repetition maximum (RM) was determined
during knee extension.
Results: Training enhanced CSA in both muscle (p < 0.001) and tendon (p < 0.01).
A trend toward a greater increase in muscle CSA was observed for OC (11%) compared
to NOC (8%) (interaction p = 0.06). Analysis of mean muscle fiber type CSA showed
a trend toward an increase in type II muscle fiber area in both groups (p = 0.11,
interaction p = 0.98), whereas type I muscle fiber CSA increased in the OC group (n = 9,
3821 ± 197 to 4490 ± 313 mm2, p < 0.05), but not in NOC (n = 7, 4020 ± 348 to
3777 ± 354 mm2, p = 0.40) (interaction p < 0.05). Post hoc analyses indicated that the
effect of OCs on muscle mass increase was induced by the OC-users (n = 7), who used
OCs containing 30 µg ethinyl estradiol (EE), whereas the response in users taking OCs
with 20 µg EE (n = 7) did not differ from NOC. Both the OC and NOC group experienced
an increase in maximal knee strength (p < 0.001) and 1RM leg extension (p < 0.001)
after the training period with no difference between groups.
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Conclusion: Use of OCs during a 10-week supervised progressive resistance training
program was associated with a trend toward a greater increase in muscle mass and a
significantly greater increase in type I muscle fiber area compared to controls. Yet, use
of OCs did not influence the overall increase in muscle strength related to training.
Keywords: exercise, estrogen, estradiol, women, muscle hypertrophy, tendon, muscle strength
INTRODUCTION
Worldwide, more than 100 million fertile young women use oral
contraceptives (OCs) for menstrual regulation and contraception
(Christin-Maitre, 2013). It has been suggested that OCs may
affect sports performance through influence on steroid hormone
receptors located in the peripheral tissues such as skeletal muscle
and tendon (Liu et al., 1996; Wiik et al., 2005; Ekenros et al.,
2017). Yet, knowledge on the effects of OC on long term
adaptations to training is sparse.
Most women use monophasic OC pill formulations
containing synthetic estrogen, ethinyl estradiol (EE) and
synthetic progesterone, progestin, in a constant dose during
the pill cycle. Depending on brand name and OC “generation,”
the formulation of EE typically varies between 20 and 50 µg
daily dose, while the different types of progestins differ in dose
depending on potency (Stanczyk, 2003; Burrows and Peters,
2007). In addition, progestins also differ in androgenocity
introducing a potential influence on adaptations to training
(Ruzic et al., 2003). Furthermore, use of OCs is associated with
reduced endogenous levels of natural estrogen, progesterone,
free testosterone and insulin-like growth factor I (IGF-I), but
enhanced levels of cortisol (Hansen et al., 2011; Zimmerman
et al., 2014; Eisenhofer et al., 2017), which may also affect the
anabolic response to training.
To study the effects of OC on exercise induced muscle growth,
resistance training seems as the optimal exercise modality
because of its well-known hypertrophic effects (Folland and
Williams, 2007). Nonetheless, only a few studies have so far
investigated the potential role of OCs in relation to adaptation
to resistance training (Ruzic et al., 2003; Nichols et al., 2008).
One study showed no difference in strength gain between users
(n = 13) and non-users of OC (n = 18) following 12 weeks of
resistance training (Nichols et al., 2008), but no information on
OC type was provided. This may be of importance since a smaller
strength gain has been reported following 16 weeks resistance
training in users of anti-androgenic OCs (EE and cyproterone
acetate, n = 26) compared to users of high androgenic OCs (EE
and levonorgestrel, n = 24) (Ruzic et al., 2003). Unfortunately, no
control group of non-OC users was included in the latter trial,
making the interpretation of the results challenging.
Changes in skeletal muscle mass are determined by the balance
between myofibrillar protein synthesis and breakdown. In users
of low androgenic OCs (EE and gestoden) myofibrillar fractional
protein synthesis rate has been reported to be lower 24 h
following one-legged kicking exercise compared to non-users of
OC (Hansen et al., 2011). The influence of OCs on myofibrillar
protein breakdown rate has not been clearly elucidated, and
has only been studied indirectly by analyzing interstitial fluid
obtained from the skeletal muscle for 3-methyl-histidine, which
did not show a difference between OC users and non-users
(Hansen et al., 2011). Based on the sparse existing data, we
therefore hypothesized, that OC use may negatively influence
the gain in skeletal muscle mass and strength in response
to resistance training compared to non-users of OC, but the
effect may depend on the type of OC (content of EE and
type of progestin).
The biomechanical properties of tendon and ligaments
improve in response to regular training (Svensson et al., 1985),
and regular resistance training has been shown to induce tendon
hypertrophy in groups of men (Kongsgaard et al., 2007) and in
a mixed group of men and women (Arampatzis et al., 2007).
However, cross-sectional data in runners suggests that the ability
to adapt to training is reduced in women (Westh et al., 2008).
Since tendon adaptations have important perspectives related
to lowering of the risk of injury in tendon and ligaments,
the effect of regular resistance training as a function of OC
use must be clarified. It has been suggested that circulating
estrogen (endogenous or exogenous) alters the risk of injuries
by changing the structural composition and adaptations to
exercise, and thereby also the mechanical properties of the tendon
(Magnusson et al., 2007; Hansen and Kjaer, 2016). In support,
estradiol increases tendon collagen synthesis and the overall
tendon collagen turnover, while it reduces tendon and ligament
stiffness (Lee et al., 2015). In contrast, use of OCs containing
EE is associated with a lower tendon collagen synthesis rate in
the patellar tendon compared to non-users both at rest and after
acute knee-extensor exercise (Hansen et al., 2008, 2009a). Yet,
no previous studies have looked into how OC use influences the
response to regular resistance training.
The overarching aim of the study was therefore to compare
adaptations in skeletal muscle and tendon to 10 weeks of
resistance training in users of low-androgenic OCs vs. NOC. We
hypothesized that OC use reduces the anabolic effect of resistance
training in the skeletal muscle and tendon.
MATERIALS AND METHODS
Subjects
Thirty young, healthy women already using 3rd generation OCs
or using no OCs were recruited through local newspapers and
included in the study. All participants were non-smokers, non-
users of medication, and without orthopedic and metabolic
disorders that would influence their participation in the training
intervention. Exclusion criteria were: resistance training more
than once every month within the last 6 months, other types of
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physical training more than 2 h per week, bike transportation
more than 20 km per day, and being on a hypocaloric diet
to reduce weight.
The 14 OC users had used OCs for 6.1 ± 5.0 years.
Third generation OCs are characterized as being low-androgenic
(Burrows and Peters, 2007). The brand names of the OCs were
Lindynette (30 µg EE and 75 µg gestoden per day, n = 7),
Gestonette (20 µg EE and 75 µg gestoden per day, n = 5),
or Novynette (20 µg EE and 150 µg desogestrel per day,
n = 2). The 14 NOCs had regular menstrual cycles for at
least 1 year (within the range of 24–35 days). The subjects
were informed about the risks and benefits associated with the
study and provided written informed consent. The protocol
followed the Declaration of Helsinki and was approved by the
Central Denmark Region Committees on Health Research Ethics
(Journal No.: M-20100187).
Design
The study compared adaptations in skeletal muscle and tendon
after 10 weeks of resistance training in OC and NOC users
(Figure 1). Each participant visited the laboratory on three
separate occasions within 1–2 weeks prior to the start of
training period (baseline). At the first visit height, weight, body
composition [Dual-Energy x-ray absorptiometry (DXA)], aerobic
fitness (VO2max/kg) determined indirectly by a submaximal
bike test (Åstrand and Rodahl, 1986), and physical activity
(MET/24 h) level determined by questionnaire (Aadahl and
Jorgensen, 2003). At the same day, the participants were
familiarized with the testing procedures of the 1 repetition
maximum (RM) and isometric dynamometer measurements to
minimize any learning effects. At the second visit magnetic
resonance imaging (MRI) of the thigh muscle and patellar tendon
were collected. MRI was performed on average 5.9 days [range
2–13 days] after the initial visit and before collection of strength
measures and tissue samples to avoid edema. At the third visit,
blood, tendon and muscle tissue samples were collected in the
morning after an overnight fast, and isometric muscle strength
was determined by dynamometry. Muscle and tendon samples
were collected in either the dominant or non-dominant leg as
determined by randomization. The isometric muscle strength
was determined in the leg that had not been biopsied. All
tests were repeated after the resistance training intervention
period (post-training). The isometric dynamometer strength was
performed on the day before the last training session. MRI data
were collected before the blood, muscle and tendon samples, at
48 or 72 h after the last training session. In addition, 4 days
of self-reported dietary intake were recorded in week 1 and
10 of the intervention period (Vitakost, Kolding, Denmark)
and recreational physical activity logs were collected during the
training intervention. The participants were asked to remain
weight-stable during the intervention.
Resistance Training Protocol
Test and training sessions were completed at the Section for
Sports Science at Aarhus University. The exercise protocol
consisted of 10 weeks of progressive resistance training
performed 3 times per week supervised by physical therapists.
Training intensities were estimated from the 1 RM test. The
exercises consisted of seated knee extensions and inclined
leg press performed in a progressive manner; week 1: 3x 12
repetitions of 15 RM; week 2–3: 3x 12 repetitions of 12 RM; week
4–5: 3x 10 repetitions of 10 RM; week 6–10: 4x 10 repetitions of 10
RM. Each training session was initiated with a 10 min warm-up
on a stationary bike. The 1 RM test of knee extension strength was
performed at the fourth training session (baseline test), and was
repeated at every third training session as well as during the last
training session of the intervention period (post-test). All subjects
were provided with a standardized amount of protein (Maxim
Pink protein bar, 10.6 g protein) after each training session.
1RM Strength Test
Participants warmed-up with 10 min ergometer cycling (60 W)
followed by six repetitions at 60% of the 1 RM predicted from the
familiarization session. The estimated starting weight was 85% of
the previous 1 RM. The load was increased or reduced until a
true 1 RM using a full range of motion was reached. Three to five
trials separated by 5 min rest was allowed. One participant from
each group was unable to perform the 1RM test after the training,
reducing n to 13 in each group.
Isometric Dynamometer Strength
Participants were seated in an isometric dynamometer (Humac
Norm, CSMi, Stoughton, MA, United States) with a hip angle
of 90◦ and strapped by the hip. The non-working leg was
FIGURE 1 | Study overview.
Frontiers in Physiology | www.frontiersin.org 3 July 2019 | Volume 10 | Article 824
fphys-10-00824 June 28, 2019 Time: 15:13 # 4
Dalgaard et al. OC Effect on Training Adaptations
positioned behind a stabilizing bar and participants were asked
to keep their arms crossed over the chest. The rotational axis
of the dynamometer was aligned with the transverse knee-joint
axis of the working leg and attached to the lower leg by a
length adjustable lever arm 3 cm proximal to malleolus medialis.
After a standardized instruction (to contract as strongly and
fast as possible) and two familiarization attempts, the subjects
performed three to five (depending on the consistency of the
first trials) maximal voluntary isometric contractions (MVIC)
for the knee extensors at a knee angle of 70◦. The subjects
received visual feedback and verbal encouragement during the
maximal contractions. All contractions were separated by at least
1 min. of rest. The attempt with the highest MVIC, defined
as peak torque measurement, was used for further analysis.
All isometric strength data were sampled and exported using
TeleMyo Direct Transmission System and MyoResearch Software
(Noraxon USA, Scottsdale, AZ, United States). A sampling
frequency of 1500 Hz was applied and the final analyses were
performed using custom-made software. To normalize data, all
strength measurements were scaled to body-weight (Jaric, 2003;
Aagaard et al., 2007).
Muscle and Tendon Cross-Sectional
Area (CSA)
Magnetic resonance imaging of muscle and tendon CSA was
performed at the MR Centre at Aarhus University Hospital,
Aarhus, Denmark. No strenuous exercise was performed within
48 h before the baseline-MRI and the post-MRI was performed
48–72 h after the last training session. This was done to
minimize the risk of an exercise induced increase in muscle
water content (Kristiansen et al., 2014). Participants were
placed in a supine position with fully extended, relaxed legs.
Muscle CSA was measured 20 cm proximal to the tibia plateau
(TP), using MR-images (Siemens Magnetom Avanto 1.5 Tesla,
Siemens AG, Munich, Germany, T1 weighted) from two lower
extremity coils. An initial image was used to determine the
proximal, lateral plateau of tibia and this point was then used
as the reference position. The muscle CSA of vastus lateralis
was manually outlined using the software program OsiriX
DICOM Viewer (version 7, OsiriX HD, 2011 Pixmeo SARL,
Bernex, Switzerland).
The Patellar tendon CSA was measured in the same scanner in
three anatomical regions directly beneath the patellar insertion
(proximal) by determining the first picture on which the
patella was not present, just above the tibia insertion (distal)
by determining the first picture on which Hoffa’s fat pat
was no longer seen, and midway between these two regions
(central), using MR-images with the following parameters:
repetition time (TR)/echo time (TE) 400/15 ms, field of
view (FOV) 160, matrix 256 × 256, slice thickness 3 mm
(Hansen et al., 2013). The MRIs of the Patellar tendon were
performed using a special knee coil placing the knee in a fixed
angle of ∼120◦. The perpendicular angle of the tendon was
set using a localizer, and axial tendon slices were obtained.
Patellar tendon CSA was manually outlined using the software
program OSIRIX 7.
For both muscle and tendon data analyses were performed by
a single technician in a blinded fashion. A mean value of three
measurements of the same image was calculated and used for
analysis (Supplementary Figure S1). The coefficient of variation
was found to be less than 5%. One participant from the NOC
group did not have an MRI scan due to claustrophobia.
Collection and Analyses of Muscle
Tissue
Participants were asked to avoid physical activity 48 h before
biopsy collection. Muscle tissue samples were collected from
m. vastus lateralis of the dominant or the non-dominant leg
determined in a random fashion using a 5 mm Bergström needle
under local anesthetic (1% lidocaine) after an overnight fast.
Muscle samples of ∼100 mg were dissected free of fat and
connective tissue, and one part was embedded in TissueTek
and then frozen in pre-cooled isopentane, and the other part
was snap frozen in liquid nitrogen. All samples were stored at
−80◦C until analysis.
Standard ATPase staining performed on 7 µm serial sections
was used to evaluate fiber type distribution and muscle fiber
CSA (Brooke and Kaiser, 1970). The serial sections were
visualized and analyzed using a Leica DM2000 microscope
(Leica, Stockholm, Sweden) and a Leica Hi-resolution Color
DFC camera (Leica, Stockholm, Sweden) combined with image-
analysis software (Leica Qwin ver. 3, Leica, Stockholm, Sweden)
essentially as previously described (Dalgas et al., 2010). Briefly,
a fiber mask was automatically drawn by the software based on
a immunohistochemically staining of the basement membrane.
This mask was fitted manually to the cell borders of the
included muscle fibers. Only fibers cut perpendicularly to their
longitudinal axis were used for the determination of fiber size.
Images of the three ATPase stainings were then fitted with the
fiber mask. Descriptive statistical analysis by the software allowed
determination of the relative proportion of the various fiber
types and fiber CSA. Blinded analyses were performed by trained
laboratory personnel. The determination of muscle fiber CSA and
typing of fibers were carried out essentially in accordance with the
procedure described by Andersen et al. (Andersen and Aagaard,
2000). Calculation of muscle fiber distribution was performed
for the three fiber types (I, IIa, and IIx) and muscle fiber CSA
was performed for the two major fiber types (I and II). For the
analysis of muscle fiber type distribution, n = 13 from each group
before and after the intervention period (average number of fiber
per subject 148 ± 3). Several of the muscle biopsy slides for
histochemical analysis were destroyed due to freeze damage and
problems with the analysis procedure. Therefore, the analysis
of changes in muscle fiber area, was performed on n = 9 for
OC and n = 7 for NOC (average number of fibers per subject
123 ± 6) and type IIx muscle fibers were not included in the
analysis due to absence or very low numbers particularly at
the post-time-point.
Muscle Protein Expression
Western blot analyses were used to assess protein expression and
phosphorylation levels of muscle proteins. Muscle samples were
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homogenized in an ice cold buffer containing (in mM) 50 HEPES,
137 NaCl, 10 Na4P2O7, 10 NaF, 2 EDTA, 1 MgCl2, 1 CaCl2,
2 Na3VO4, 1% (vol/vol) Nonidet P-40, 10% (vol/vol) glycerol,
2 µg/ml aprotinin, 5 µg/ml leupeptin, 0.5 µg/ml pepstatin,
10 µg/ml antipain, 1.5 mg/ml benzamidine, and 100 µM
4-(-2-aminoethyl)-benzenesulfonyl fluoride, hydrochloride (pH
7.4), and rotated for 60 min at 4◦C. Subsequently, the
samples were centrifugation at 14,000 × g for 20 min at
4◦C and the pellet discharged. With this method, we have
previously been able to detect many skeletal muscle proteins,
however, we might also lose proteins of interest (Murphy
and Lamb, 2013). Protein concentration in the supernatant
was determined using the Bradford assay. After separating the
proteins by gel electrophoresis and blotting them on to a
PVDF membrane, the membranes were incubated overnight
with the following antibodies: from Cell Signaling Technology
(MA, United States): mTOR (cat. no. 2972), p-mTOR Ser2448
(cat. no. 2971), p70S6K (cat. no. 9202), eIF4E (cat. no. 9742),
AKT-pan (cat. no. 4691), p-AKT Ser473 (cat. no. 9271), 4EBP1
(cat. no. 9644), non-p-4EBP1 Thr46 (cat. no. 4923), and LC3B
(cat. no. 3868); from Abcam (Cambridge, United Kingdom):
Fbx32 (cat. no. ab92281) and MURF1 (cat. no. ab172479).
Horseradish peroxidase (HRP)-conjugated goat anti-rabbit or
goat anti-mouse IgG were used as secondary antibodies and
visualized by BioWest enhanced chemiluminescence (Pierce).
Quantification was performed using UVP Bio Imaging System
software (UVP, Upland, CA, United States). Expression of
both non-phosphoprotein and phospho-protein are presented as
ratios of target protein to total protein load quantified using the
Stain Free Technology. Due to difficulties in obtaining enough
muscle tissue, the analysis was performed on n = 8 for OC and
n = 12 for NOC.
Tendon Samples
Tendon biopsies were randomly obtained from the dominant
or the non-dominant leg, according to procedures described
in detail elsewhere (Hansen et al., 2009c; Kongsgaard et al.,
2010). In brief, following sterilization of the insertion site, the
skin was injected with local anesthetic (1% lidocaine), and
a 3- to 5-mm-long incision was made distally to the patella
apex. A tendon biopsy was obtained by using a 16-G Monopty
biopsy instrument (Bard, Covington, GA, United States) with
a disposable core biopsy needle (14 gauge). The biopsy needle
was inserted into the tendon surface at a ∼30◦ angle and
fired, securing a tissue sample of approximately 8–10 mg.
The tissue sample was cleared of external adipose tissue and
blood, snap-frozen in liquid nitrogen and stored at -80◦C for
subsequent analysis.
Biochemical analysis of collagen cross-links was performed as
previously described in details (Hansen et al., 2013).
Freeze-dried tendon samples were hydrolyzed and re-
dissolved in H2O. The collagen-specific cross-linking compounds
hydroxylysyl pyridinoline (HP), lysyl pyridinoline (LyP), and
pentosidine were analyzed spectrophotometrically by reversed-
phase high-performance liquid chromatography (HPLC) to
quantify collagen protein (Creemers et al., 1997).
Analyses of Blood Parameters
All blood samples were taken in the morning after an overnight
fast (<6 h) and from an antecubital vein. Serum albumin,
estradiol, progesterone, testosterone, and sex hormone binding
globin (SHBG) were determined at baseline and after the training
intervention (post) by standard procedures performed at the
Department of Clinical Biochemistry at the Aarhus University
Hospital. For each variable, all samples were measured in
the same assay run.
Statistical Analyses
All data are reported as means ± SE unless stated otherwise.
All data were tested for normal distribution by visual inspection
and using a Shapiro-Wilk normality test. Statistical analyses for
differences between OC and NOC in subject characteristics,
serum hormones levels, fibril characteristics and tendon content
of collagen and cross-links were performed using an unpaired
t-test. A paired t-test was used to test for differences
between baseline and post-in serum albumin, progesterone and
testosterone. The log-transformed normal distributed data for
FM, weight, PAL and BMI was used in an unpaired t-test since
the data did not pass the normality test. Estradiol and SHBG
did not pass normality tests even after log-transformation, thus
a Wilcoxon Signed-Rank test was used to test for significance in
the raw data between OC and NOC.
Test for difference in muscle CSA, muscle fiber CSA, muscle
strength, tendon CSA and tendon cross-links caused by training
load or use of OC was performed using a two-way ANOVA
with repeated measurements followed by a Holm-Sidak post hoc
test. Data for tendon CSA at the mid and distal level only
passed the normality test after log-transformation. Therefore,
log-transformed data for these parameters were used in the
analysis. Unpaired t-tests were performed to test for differences in
response to training in muscle CSA between different types of OC
(containing either 20 or 30 µg EE/pill) and NOC. A Spearman
correlation was used to test the association between daily protein
intake per kg bodyweight and change in muscle CSA after the
intervention. The level of significance was set at p ≤ 0.05, while
p ≤ 0.10 was designated as a trend. The following labels were
used: ∗∗∗p < 0.001, ∗∗p < 0.01, and ∗p ≤ 0.05 unless stated
otherwise. The statistical analyses were performed using the
statistical software package Sigma Plot version 13.0.
RESULTS
The OC and NOC groups were comparable regarding age,
height, weight, body mass index (BMI), physical activity level
(MET/24 h), aerobic fitness (VO2max/kg), and body composition
(Table 1). The recreational activity logs were checked for changes
in activity level during the intervention period, but none of the
participants performed strenuous physical training more than 2 h
per week and no additional resistance training was performed
besides the intervention. Every one of the included participants
completed the study. All participants followed and received
individual supervision for each training session, and compliance
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TABLE 1 | Subject characteristics.
NOC (n = 14) OC (n = 14)
Age (years) 24 ± 1 24 ± 1
Height (m) 1.67 ± 0.02 1.68 ± 0.02
Weight (kg) (Baseline) 66.7 ± 2.1 65.6 ± 3.6
Weight (kg) (Post) 67.3 ± 2.1 66.6 ± 4.1
BMI (kg·m−2) 24 ± 1 23 ± 2
Body Fat (%) 32 ± 2 32 ± 2
Aerobic fitness, VO2max (ml·min−1·kg−1) 32 ± 2 35 ± 3
Physical activity level (MET/24 h) 1.8 ± 0.1 1.6 ± 0.1
Use of OC (years) 0 ± 0 6 ± 1∗∗∗
BMI, body mass index; Aerobic fitness, maximal oxidative uptake of oxygen/min/kg
body weight; OC, oral contraceptives; NOC, non-users of oral contraceptives. No
significant differences existed between groups except for use of OC (∗∗∗ denotes
p < 0.001). Values are mean ± SE.
with the training protocol was 100%, as any missed training
session was performed another day within the same week.
Fourteen OC and 14 NOC users were eligible to be included
in the analysis. Two NOC were excluded before the analysis,
since they had deliberately reduced their energy intake in the
intervention period and lost 8.4 and 7.3% in body weight,
respectively, which may have reduced the anabolic potential of
resistance training on muscle growth.
Muscle CSA and Muscle Fiber CSA
Resistance training induced an increase in muscle CSA in both
OC (10.8 ± 1.3%, p < 0.001) and NOC users (7.9 ± 0.09%,
p < 0.001) (Figure 2A and Supplementary Figure S1).
Furthermore, a trend toward interaction between OC status and
training effect was observed (p = 0.06), which indicated a greater
increase in muscle CSA in the OC group than in the NOC group.
OC sub analysis indicated that the increased muscle mass was
driven by the OC-users (n = 7), who used OCs containing 30 µg
EE, whereas the response in users taking OCs with 20 µg EE
(n = 7) did not differ from NOC (30 vs. 20 µg EE: 13.1 ± 1.7%
vs. 8.5± 1.4%, p = 0.08. 30 µg EE vs. NOC: p = 0.01. 20 µg EE vs.
NOC: p = 0.73) (Supplementary Figure S2).
For type I muscle fiber CSA, the two-way ANOVA
demonstrated a significant interaction between OC status and
time (p = 0.04) (Figure 2B). In OC users, type I muscle fiber CSA
was significantly greater after the training period (3821 ± 197 to
4490 ± 313 µm2, p < 0.05), whereas no significant change was
observed in NOC users (NOC: 4020 ± 348 to 3777 ± 354 µm2,
p = 0.40). Type II muscle fiber CSA showed a non-significant
increase after the training period (p = 0.11) in both groups
(OC: 3452 ± 242 to 3891 ± 387 µm2, NOC: 3239 ± 344 to
3691± 361 µm2), but no interaction between OC status and time
was observed (p = 0.98) (Figure 2C).
The training intervention induced a change in muscle fiber
type distribution (Table 2). The training intervention reduced the
relative number of type IIx muscle fibers (p < 0.001), while the
relative type IIa muscle fiber number increased (p < 0.05). The
changes in type IIx muscle fiber number (p = 0.05) was greater in
OC than NOC. In contrast, type I muscle fiber relative number
did not significantly change after the intervention.
FIGURE 2 | Changes in muscle CSA and muscle fiber CSA. (A) Change in
muscle cross-sectional area (mm2) in OC and NOC users (n = 14 and n = 13,
respectively) from baseline to post-training. Change in cross-sectional area
(µm2) of type I (B) and type II (C) muscle fibers in the OC and NOC group
(n = 9 and n = 7, respectively) from baseline to post-training. OC is illustrated
by closed circles, while NOC are shown by open circles. The horizontal line
denotes mean ± SE. (∗) denotes a trend (p = 0.66), while a ∗ denotes
p < 0.05.
Muscle Strength
Absolute muscle strength increased in both OC and NOC users
following the training intervention as measured by 1RM test
(OC: 18.2 ± 3.6% vs. NOC: 15.4 ± 1.6%; time p < 0.001)
and MVIC (OC: 17.3 ± 3.6% vs. NOC: 13.8 ± 3.5%; time
p < 0.001). Larger absolute increases were observed in the
OC users, however, no significant difference between the two
groups was observed in 1RM (interaction p = 0.46) and MVIC
(interaction p = 0.36). Normalizing data to individual baseline
Frontiers in Physiology | www.frontiersin.org 6 July 2019 | Volume 10 | Article 824
fphys-10-00824 June 28, 2019 Time: 15:13 # 7
Dalgaard et al. OC Effect on Training Adaptations
TABLE 2 | Muscle fiber type distribution.
OC (n = 13) NOC (n = 13) Two-way ANOVA RM
Fiber type% Baseline Post Baseline Post Training Group Interaction
Type I 46.9 ± 2.8 48.3 ± 2.5 53.4 ± 2.7 52.4 ± 2.9 0.91 0.13 0.52
Type IIa 42.6 ± 2.5 47.7 ± 2.5 39.4 ± 2.6 42.8 ± 2.1 < 0.05 0.16 0.64
Type IIx 10.5 ± 2.2 3.9 ± 1.5 7.1 ± 2.1 4.8 ± 1.2 < 0.001 0.59 0.05
The relative distribution (%) of type I, type IIa, and type IIx muscle fibers in OC users and NOC users is shown. Data are reported as mean ± SE.
and post-body weight (bw) did not influence the results (1RM;
OC: 1.12 ± 0.05 kg/kg bw (baseline) vs. 1.29 ± 0.05 kg/kg
bw (post); NOC: 1.05 ± 0.09 kg/kg bw (baseline) vs.
1.20 ± 0.10 kg/kg bw (post), p < 0.001 for training effect,
interaction p = 0.66. MVIC; OC: 3.0± 0.14 Nm/kg bw (baseline)
vs. 3.5 ± 0.18 Nm/kg bw (post); NOC: 3.0 ± 0.17 Nm/kg
(baseline) vs. 3.3± 0.19 Nm/kg (post), p = 0.01 for training effect,
interaction p = 0.56) (Figure 3).
Muscle Tissue Protein Expression
The mTOR expression increased with time (p < 0.05), while
Murf-1 showed a trend toward a decrease at the post-time point
(p = 0.08). eIF4E and p70S6K showed a positive interaction
between time and OC-status (p < 0.05) revealing an decreased
expression in OC users and an increased expression in NOC
users after the training period. In contrast, protein expression
of mTORSer2448, Akt2, AktSer473, 4EBP1, 4EBP1Thr46(non−p),
Atrogin-1, and the ratio of LC3B-II/LC3B-I were not different
between OC and NOC groups (Supplementary Figure S3).
Tendon Cross Sectional Area and
Cross-Links
Tendon CSA (proximal, mid, and distal) did not differ between
the dominant and non-dominant leg and only average values
for both legs are shown in Table 3. After the training
period, tendon CSA at all three levels (proximal, mid,
and distal) was significantly increased compared to baseline.
However, no difference between groups was observed in the
response to training.
Analysis of tendon collagen content (dry weight), and
cross-links (fractions of HP, LyP, and pentosidine) was
performed in 14 OCs and 11 NOCs, since attempts to
obtain a tendon biopsy were not successful in three
NOCs (Table 3). A trend for higher concentration of
HP in the OC than the NOC group was observed
(p = 0.07), but otherwise no group difference between
OC and NOC or difference in response to training were
observed (Table 3).
Blood Parameters
At baseline and post-training, serum (s-) albumin and s-SHBG
were higher in OC users compared to NOC, whereas s-estradiol,
s-progesterone, and s-testosterone were lower in the OC
compared to the NOC group (Table 4). S-estradiol was
below the detection limit in 11 out of 14 OC-users at
baseline and 8 out of 14 OC users after the intervention.
The SHBG level in NOC users was higher post-training
than at baseline (p < 0.001). Similarly, NOC mean serum
progesterone tended to be higher after the intervention vs.
baseline (p = 0.06).
Energy and Macronutrient Intakes
Eating habits were not different at week 1 and 10 of
the intervention. Therefore, only average energy and
macronutrient intake from the two periods are included in
Table 5. One subject from each group was excluded from
the analysis due to unreliable energy intake registration
based on cut-off values (Goldberg et al., 1991), despite that
all subjects were weight-stable during the intervention. No
significant difference in energy intake, fat, carbohydrate
and protein intake was observed between groups, but
the protein intake per kg body mass was higher in
OC than NOC users.
FIGURE 3 | Changes in muscle strength. (A) Difference in 1 repetition maximum (1RM) in OC and NOC users from baseline to post-training (kg) (n = 13 in each
group). (B) Changes in maximum voluntary isometric strength (MVIC) in users of OC and NOC users from baseline to post-training (Nm/Kg Bw) (n = 14 in each
group). Bw, body weight; OC, closed circles; NOC, open circles. The horizontal line denotes mean ± SE.
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TABLE 3 | Tendon CSA, and concentrations of collagen and collagen cross-links.
OC (n = 14) NOC (n = 14) Two-way ANOVA RM
Baseline Post Baseline Post Training Group Interaction
Tendon CSA proximal 81 ± 6 87 ± 5 77 ± 3 85 ± 5 < 0.05 0.71 0.70
Tendon CSA middle 78 ± 4 90 ± 4 80 ± 3 97 ± 7 < 0.001 0.37 0.57
Tendon CSA distal 95 ± 5 101 ± 5 100 ± 5 109 ± 5 < 0.05 0.31 0.57
OC (n = 14) NOC (n = 11)
Baseline Post Baseline Post Training Group Interaction
Collagen 0.62 ± 0.02 0.64 ± 0.02 0.61 ± 0.03 0.62 ± 0.04 0.61 0.66 0.72
HP/Collagen 0.73 ± 0.06 0.80 ± 0.05 0.63 ± 0.06 0.65 ± 0.06 0.39 0.07 0.56
LyP/Collagen 0.03 ± 0.02 0.03 ± 0.00 0.04 ± 0.01 0.03 ± 0.00 0.18 0.81 0.13
Pentosidine/Collagen 0.012 ± 0.001 0.012 ± 0.001 0.011 ± 0.001 0.012 ± 0.001 0.47 0.46 0.44
CSA (mm2) at the proximal, middle and distal part of the patella tendon in OC users and NOC users is reported along with collagen concentration (mg/mg d.w; dry weight)
and collagen cross-links of tendon as fractions of HP, LyP, and pentosidine relative to collagen (pmol/pmol). Data are shown as mean ± SE.
TABLE 4 | Blood parameters.
NOC (n = 14) OC (n = 14) P-values
Albumin (g/L) Baseline 42 ± 1 46 ± 1 < 0.01
Post 42 ± 1 46 ± 1 < 0.05
Estradiol (nmol/L) Baseline 0.45 ± 0.06 11 out of 14 < 0.05 nmol/L < 0.05
Post 0.72 ± 0.17 8 out of 14 < 0.05 nmol/L < 0.05
Progesterone (nmol/L) Baseline 15.2 ± 4.2 1.1 ± 0.1a < 0.01
Post 27.2 ± 8.8 1.1 ± 0.2b < 0.05
Testosterone (nmol/L) Baseline 1.18 ± 0.14 0.76 ± 0.07 < 0.05
Post 1.35 ± 0.12 0.90 ± 0.09 < 0.05
SHBG (nmol/L) Baseline 57 ± 6 204 ± 14 < 0.01
Post 65 ± 7# 224 ± 13 < 0.01
Serum concentrations of albumin, estradiol, progesterone, testosterone, and sex hormone binding globin (SHBG) in OC and NOC at baseline and post-training is reported.
Data are shown as mean ± SE. a2 out of 14 in OC had a progesterone level < 0.03 nmol/L. bOne out of 14 in the OC group had a progesterone level <0.03 nmol/L.
A # designate a significant difference between baseline and post-training values, p < 0.05. P-values designate differences between OC and NOC.
TABLE 5 | Energy and macronutrient intake.
OC (n = 13) NOC (n = 13) P-values
Energy intake (kJ/day) 8390 ± 1960 8630 ± 1716 0.74
Carbohydrates, E% 52 ± 4 49 ± 4 0.07
Fat, E% 27 ± 4 30 ± 6 0.17
Protein, E% 17 ± 4 15 ± 2 0.06
Protein, g/day 81 ± 10 74 ± 14 0.15
Protein g/kg bw/day 1.3 ± 0.2 1.1 ± 0.2 0.03
The average of two 4-day self-reported food records performed in week 1 and 10
of the intervention is shown for OC and NOC. E%, % of total daily energy intake;
Bw, body weight. Data are shown as mean ± SE.
DISCUSSION
Studies investigating the influence of OCs on adaptation to
resistance training are very few and conflicting. Here, we present
the first data based on a controlled intervention focused on
elucidating the effect of a single type of OC (3rd generation).
Furthermore, the participants performed one-on-one supervised
resistance training with a high level of compliance and a
controlled progressive overload. These factors are important
when interpreting the results since other studies have used a mix
of OCs (Ruzic et al., 2003; Nichols et al., 2008; Ekenros et al.,
2013; Wikstrom-Frisen et al., 2017) and failed to improve muscle
strength following the resistance training intervention probably
due to a less controlled (and intense) training intervention
(Wikstrom-Frisen et al., 2017).
Contrasting to our hypothesis, a trend toward a larger
increase in muscle mass (MRI) (p = 0.06) was observed in
OC compared to NOC users (11 vs. 8%). This contrasts our
expectations based previous data showing a lower myofibrillar
fractional protein synthesis rate in OC users of a similar type
of low androgenic OC (EE and gestoden) compared to NOC
(Hansen et al., 2011). Previous exercise studies in the field
have failed to show any clear effect of OC on adaptation to
resistance training. For example, one study by Nichols et al.
(2008) showed no difference between OC and NOC in muscle
strength gain after a 12-week strength period; however, included
users of different types of OCs and included different types of
athletes, who continued their discipline-specific training during
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the intervention (Nichols et al., 2008). These factors may have
introduced bias and thereby limited the possibility of detecting
group differences. The type of OC may influence the response
to training as reported by Ruzic et al. (2003), who compared
the effect of 16-weeks of resistance training in users of OCs
containing either EE and the anti-androgen cyproterone acetate
or EE and levonorgestrel (Ruzic et al., 2003). The latter group
showed an increased gain in fat-free mass and muscle strength
after the intervention compared to the first group, indicating
either an anti-anabolic effect on skeletal muscle of the anti-
androgen OCs or a stimulating effect of the OC containing
levonorgestrel. The lack of a NOC control group leaves this
comparison unresolved, but the data underline the need for
elucidating the isolated effect of the different types of OCs on
training adaptabilities.
Muscle hypertrophy is experienced when the average
myofibrillar protein synthesis rate over time exceeds the
average myofibrillar protein breakdown rate (Sandri, 2008). Our
findings suggest that 3rd generation OCs containing gestoden
or desogestrel influences net balance in response to exercise.
To investigate molecular mechanisms underlying this effect,
we analyzed intracellular signaling proteins involved in protein
synthesis and degradation. One key regulator of muscle protein
synthesis, mTOR increased in response to training in both
groups. Furthermore, the E3 ligase MURF1 that recruits proteins
for degradation in the proteasomes, tended to decrease only in
the OC group, which is consistent with the observed greater
muscle gain (p = 0.06) in OC than NOC. Although we did
observe small changes in eIF4E and p70S6K, the remaining
signaling proteins remained unchanged. Consequently, with this
study, the changes in muscle mass does not seem to correlate
with consistent changes in the investigated intracellular signaling
proteins. However, the present study collected only resting
biopsies and as such was not designed to investigate molecular
mechanisms; thus, future studies should attempt to investigate
the acute effect of OCs in relation to exercise training.
The included OC users had been using OCs for at least
3 months prior to the training period. Therefore, the latter
findings suggest that use of OCs has a positive synergetic effect
on resistance training response at the myocellular level. The
activation of skeletal muscle signaling pathways by OCs when
combined with regular training may involve activation of the
estrogen receptors within the skeletal muscle. In support of
this notion, human data have shown upregulation of myogenic-
related gene expression after exercise when estrogen receptor α
is activated (Haines et al., 2018). Our previous findings showed
lower myofibrillar synthesis rate compared to control in users of
OCs containing gestoden, but not levonorgestrel (Hansen et al.,
2011), while the study by Ruzic et al. (2003) showed a greater
increase in muscle strength and mass in levonorgestrel-users.
These results suggest that the 3rd generation OCs containing low-
androgen progestin (gestoden or desogestrel) reduces the muscle
hypertrophic effect of resistance training compared to more
androgenic types of OCs such as levonorgestrel. In the present
trial, we only included users of 3rd generation OCs, but with a
variable content of EE. Post hoc analysis of our data indicates the
possibility that the potentiated hypertrophic effect of training and
OCs on muscle mass may be related to EE concentration of the
applied OC. This opens the possibility that EE in the OCs plays
a direct stimulatory role when combined with regular resistance
training. Still, it is unknown how such a stimulatory effect
would be mediated. Previous studies utilizing postmenopausal
women as an estrogen depleted-model, showed no effect of
estrogen on myofibrillar FSR (Smith et al., 2014), however,
the combined effect of estrogen supplementation and exercise
increased myofibrillar FSR compared to controls (Hansen et al.,
2012) implying an enhanced stimulating effect of estrogen on
the exercise induced anabolic stimuli, which supports the current
findings. We speculate that while endogenous estrogen levels
fluctuate during the menstrual cycle, monophasic OCs provide
an exogenous steady state level of EE introducing a continuous
stimulus on the intramuscular ERs during day 1–21 of the
OC cycle, which could provide the enhanced anabolic stimulus.
Furthermore, EE is more potent than the endogenously produced
17β-estradiol in inducing estrogenic effects in women (Coelingh
Bennink, 2004). Therefore, EE may influence myogenic gene
expression directly as suggested by the present findings.
Another way OCs may influence the response to resistance
training is by increasing recovery time (Minahan et al., 2015).
It can be speculated that when exercising regularly, a delayed
recovery between exercise sessions may induce a greater
stimulatory response on muscle hypertrophy, but this statement
needs to be investigated in future studies. Other factors that could
potentially influence muscle mass in OC users are related to
the changes in the endogenous hormone profile. Higher resting
and exercise-induced GH levels have previously been observed
in OC users compared to NOC users (Kraemer et al., 2008),
while testosterone and IGF-1 levels have found to be lowered
by OC (Hansen et al., 2009b). The effect of GH and IGF-I on
muscle growth in humans is not clear (Heinemeier et al., 2012),
but GH and IGF-I likely have a stimulatory effect on protein
synthesis in the muscle connective tissue, ligaments and tendon,
rather than stimulating myofibrillar protein synthesis (Doessing
et al., 2010a) rate and muscle mass itself (West et al., 2009).
However, it cannot be ruled out that a higher GH level in OC
users may have had a positive regulatory influence on satellite
cells, since the numbers of satellite cells increase in human muscle
with increased GH/IGF-I levels (Doessing et al., 2010a,b). In
the current study, serum testosterone was lower in OC users,
whereas SHBG was higher compared to NOC users. This suggests
that the level of free testosterone is also reduced, which is a
well-documented observation (Zimmerman et al., 2014). Since
testosterone has a stimulatory effect on muscle protein synthesis
(Smith et al., 2012), the lower level of free testosterone in the OC
users is not the explanatory factor for the enhanced muscle gain
in the OC-users.
Likewise, progesterone is lower in OC users, which was also
documented in the present study. The impact of progesterone on
muscle mass is uncertain. Smith et al. found that skeletal muscle
protein synthesis rate in post-menopausal women increases
after progesterone administration (Smith et al., 2014). This
could suggest an anabolic effect of progesterone. However,
progesterone has also been proposed to exert a catabolic effects
on skeletal muscle based on a higher lysine requirement observed
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in women during the luteal phase (Kriengsinyos et al., 2004), and
greater urinary urea N excretion and total urea N excretion in
sweat and urine in the ML phase compared to menses (Lamont
et al., 1987), but data regarding resistance exercise are missing
(Oosthuyse and Bosch, 2010). If progesterone has a catabolic
effect on skeletal muscle mass, the lower level of progesterone
in OC users could partly explain the greater muscle gain.
Nevertheless, OCs also contain a synthetic form of progesterone
(gestoden or desogestrel). The isolated effect of the progestin
cannot be elucidated from the present in vivo study as only
the combined effect OC containing both EE and progestin
was investigated.
Resistance training aimed at increasing muscle hypertrophy
and muscle strength as in the present study, generally increase
CSA of the fast type II muscle fibers (Andersen and Aagaard,
2000). Accordingly, we observed non-significant increases in type
II muscle fiber CSA in both OC and NOC and a shift from type
IIx to type IIa muscle fibers. The decrease in type IIx underline
that the resistance training program was effective in this group of
previous untrained women. To our surprise, the CSA of the slow
type I muscle fibers increased, but this was found in the OC users
only. This observation for type I muscle fibers is supported by
a study reporting a larger effect of phytoestrogen containing soy
proteins on type I CSA as compared to whey protein or placebo
(Haun et al., 2018). In line with this, testosterone supplement in
strength training males seems to increase the growth of both type
I and type II muscle fibers, whereas strength training alone is
documented to primarily target type II fibers (Kadi et al., 1999;
Kadi, 2000; Eriksson et al., 2005). In addition, it has been shown
that type I muscle fibers have an enhanced sensitivity to hormonal
anabolic stimuli (Hartgens et al., 1996), suggesting similar actions
of the endogenous male and female sex hormones testosterone
and estrogen directed is able to target both type I and type II
muscle fibers and amplify the anabolic effect of strength training.
In support of this, ER-β subtype selective agonist treatment in
ovariectomized Wistar rats led to increased expression of Pax7
mRNA in the slow soleus muscle and increased muscle fiber
size of type I muscle fibers (Weigt et al., 2012). Collectively,
these observations may indicate that the EE component in OC
positively influence the satellite cells associated with type I muscle
fibers and thereby support an increased anabolic stimuli of OC,
when combined with strength training. Nevertheless, further
human studies are needed to confirm these findings.
The increase in muscle strength was not different between OC
and NOC users (1RM 18 vs. 15%, MVIC 17 vs. 14%) even though
the muscle hypertrophy tended to be greater in OC than NOC
users (11 vs. 8%, interaction p = 0.06). Several factors may help
to explain this observation. Neural and neuromuscular factors
influence muscle strength (Moritani and deVries, 1979), as well
as the levels of endogenous and synthetic female hormones
may influence strength performance acutely on the day of
testing (Sung et al., 2014), as indicated by a study in rodents
showing a positive influence of estrogen on myosin structure
and contractility (Lai et al., 2016). Variation in endogenous
and exogenous female hormones between test-days may have
introduced noise and thereby hindered the possibility of detecting
differences in muscle strength. A prolonged training period
and a greater samples size would have enhanced the possibility
to detect a difference in muscle strength parameters between
groups. Even small improvements in muscle mass and strength
adaptations during a training period induced by OC use would
be of great importance for e.g., elite athletes, but probably not
be of clinical relevance during daily life activities in the general
female population.
Tendon Cross Sectional Area and Cross
Links
There are very few studies investigating the role of female sex
hormones on tendon tissue, yet, previous studies have indicated
a lower tendon collagen FSR in women compared to men at
rest and in response to exercise (Miller et al., 2006, 2007).
Furthermore, Westh et al. (2008) did not detect any difference
in Achilles and Patellar tendon CSA between experienced female
runners and sedentary controls, whereas a greater tendon CSA
was observed in the male runners after adjustment for body
weight (Westh et al., 2008). In support, 9 month of running (in
total 43 h) lead to a 9% increase in VO2max, but no change in
Achilles tendon CSA (Hansen et al., 2003). These observations
indicate a reduced ability to increase tendon CSA in female
athletes compared to male athletes. Nevertheless, in the present
study we observed an increase in tendon CSA in the mid portion
of the patella tendon in both OC and NOC users, indicating
that women show tendon adaptations to resistance training
interventions. In support, female handball players show a trend
toward a greater tendon CSA, when comparing the preferred
jumping leg with the contralateral leg (P = 0.09) (Hansen et al.,
2013). These observations are in contrast to the observation by
Westh et al. (2008). An explanation for the discrepancy may
be that they included female runners, in whom, a low energy
intake and disturbance in hormonal profile may have hampered
their ability to adapt (Farup et al., 2014; Maughan et al., 2018).
Another explanation might be that the loading threshold for a
hypertrophic effect of regular mechanical loading is higher in
women than in men and the stimulating effect of running may
be below that threshold.
Both OC and NOC increased tendon CSA. Previous
observations showed a lower tendon collagen synthesis rate in
OC compared to a NOC group at rest (Hansen et al., 2009b)
and in response to exercise (Hansen et al., 2008), which was
speculated to be caused by a lower bioavailability of IGF-I locally
in the tissue and blood in OC-users (Maughan et al., 2018).
In support of a slower tendon collagen turnover in OC-users,
we in the present study observed a tendency toward a greater
content of HP compared to NOC (group effect, p = 0.07) (Hansen
and Kjaer, 2016). Based on this, we expected to see a hampered
response to training in tendon CSA in the OC users compared
to NOC. On the other hand, if OC enhances the gain in muscle
mass as suggested by the present findings, this may increase the
loading on tendon and ligaments during maximal locomotion
and thereby enhance the stimulatory effect of exercise on tendon
adaptation. In support, cross-sectional data from experienced
female handball players show greater tendon CSA adjusted for
body weight (mm2/kg2/3) of the jumping leg compared with the
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contralateral leg at the distal level of the patellar tendon in OC
users, but not in NOC users (p = 0.98, interaction p = 0.08)
(Hansen et al., 2013).
In the present study, we did not observe any increase in CSA
neither in the distal nor in the proximal parts of the tendon in
the OC group, while the NOC users increased CSA in all three
parts of the tendon. On top of a higher content of tendon HP
cross-links supports the notion of a slower collagen FSR in users
of OC compared to NOC (Hansen et al., 2008). In addition, the
improved gain in muscle mass in OC users compared to NOC,
along with a comparable increase in tendon CSA, may indicate
that OC users need more time to adapt in tendon than in the
contractile muscle pointing at a mismatch in adaptation between
tissues and an increased risk of injury. Further elucidation of
this aspect is needed, but the observation should be kept in
mind when female athletes using OCs are adapting to new or
increased training loads.
Methodological Considerations
Use of OC or NOC was not randomized in our study, and
non-training groups would be required to clarify the entire
effect of OC-initiation on muscle mass and strength. On the
other hand, a strength of the present study where we included
habitual users of OC, is that they have bypassed any transient
changes taking place in the first months after initiation of
OC use, such as changes in endogenous hormones (e.g., lower
endogenous estradiol and testosterone levels and increasing
SHBG levels) and mental side-effects (Kuhnz et al., 1993;
Skovlund et al., 2016). If OC use was initiated concurrent with
the exercise intervention, we would be unable to separate the
effects of the two.
We did not control for the time-point in menstrual cycle
phase/pill cycle when testing muscle strength. This was done so,
as our primary outcome parameter in the study was potential
improvements in skeletal muscle mass with training, and thus,
we aimed for an equal number of training sessions between
individuals of the groups. Should the menstrual cycle have been
taken into account, it would have been necessary to include
a different number of exercise sessions based on differences
in the length of the menstrual cycle (e.g., 25 vs. 35 days) or
changed the recovery length between exercise sessions. Both
adjustments might have affected the results in regards to muscle
mass gain, and thus, conflicted with the primary goal of the
study. Nevertheless, the lack of control for the menstrual cycle
time-point may have introduced variations during our strength
testing. In the NOC users, the progesterone level was higher in
8/13 women when testing after the training period compared
to baseline, whereas it was lower only in 2/13 and comparable
in the last 3/13 subjects. This suggests that a greater number
of NOC users were within the luteal phase of menstrual cycle
when testing after the intervention compared to before the
intervention. The literature within this area report conflicting
data. Some studies have found a greater maximum voluntary
force production around the time of ovulation (Phillips et al.,
1996; Sarwar et al., 1996; Iwamoto et al., 2002), while others
report no variation in strength parameters between menstrual
phases (Constantini et al., 2005; Lebrun et al., 2013). Yet, such
variations in performance may have weakened our possibility
for detecting a difference in strength gain between the study
groups. The training period was 10 weeks in the present trial.
The results from a few training studies indicate that the gain in
muscle mass and strength is greater when the training sessions
are concentrated in the follicular phase rather than in the luteal
phase or equal distributed during the cycle (Reis et al., 1995; Sung
et al., 2014; Wikstrom-Frisen et al., 2017). However, others have
reported no difference in adaptation to resistance training related
to the timing of the training sessions in different menstrual
phases (Sakamaki-Sunaga et al., 2016). In light of an average
28-day menstrual cycle, it would in theory have been optimal,
if the training period was 12 weeks corresponding to three
average cycles. The training sessions were equally distributed
each week during the training period; thus, we cannot rule
out that some participants have performed a larger part of
their training within the follicular phase, related to timing of
the menstrual cycle. As discussed previously, it is difficult to
control the latter.
The participants collected 4-day dietary records. The results
indicated a rather low energy intake considering that the subject
are young and exercising three times per week, while also
remaining weight stable throughout the 10-week intervention.
This suggest that the two 4-day dietary records are not
representative of the total amount of energy really consumed
during the 10 weeks of training.
The dietary records also indicated a lower protein intake
per kg body weight in the NOC users compared to the
OC users (Table 5). This could potentially have lowered
the ability of the NOC users to synthesize new myofibrillar
protein and thereby gain muscle mass. However, we observed
no correlation between muscle gain measured by MRI and
protein intake in the participants (OC r = 0.045, p = 0.88;
NOC r = 0.37, p = 0.24) (Supplementary Figure S4). This
indicates that the reported lower protein intake in NOC
may not have influence the gain in muscle mass in the
present study. It is worth noticing that self-reported dietary
intake is subject to misreporting (Bokhof et al., 2010), which
question the validity of self-recorded food records in general.
In any case, to ensure an equal availability of amino acids
for myofibrillar protein synthesis in the hours after each
exercise session, the participants in both groups ingested a
standardized protein bar immediately after every training session
(Andersen et al., 2005).
CONCLUSION
The present results suggest that habitual users of monophasic
3rd generation OCs experience a tendency toward a potentiated
anabolic effect of resistance training on skeletal muscle mass
compared to NOC. Moreover, we demonstrate that untrained
women can increase patellar tendon size in response to regular
resistance training irrespective of OC use. Despite the trend
toward altered muscle adaptation to resistance training with the
use of OC, this did not significantly influence the muscle strength
improvement following strength training in young women.
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